This compound is a modified uridine phosphoramidite building block specifically designed for the solid-phase synthesis of RNA oligonucleotides. Its structure incorporates a 2'-O-propyl protection group, a 5'-O-(4,4'-dimethoxytrityl) (DMT) group, and a 3'-O-(diisopropylamino-2-cyanoethoxyphosphanyl) group, enabling its use as a key monomer in automated RNA synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 160526-54-5
2'-O-Hexadecyl-U-CE-Phosphoramidite
pharmaceutical intermediate
DMTr-2'-O-C22-rU-3'-CE-Phosphoramidite
pharmaceutical intermediate
5'-O-DMT-2'-(2-methoxyethyl)uridine 3'-CE phosphoramidite
pharmaceutical intermediate
5'-O-(4,4-Dimethoxytrityl)-2'-O-methyluridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
pharmaceutical intermediate
Perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate
research compound
1-aminopyrene
research compound
Dicyclohexano-18-crown-6
research compound
Octreotide Impurity 38
research compound
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-propoxyoxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
YUKSSAHYYXKOAN-CYSIDSPMSA-N
CCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N
—